← Leaderboards
Shaodong Guo
Texas A&M Agrilife Research
$4,898,872
Attributed
$4,898,872
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $877.7K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,898,872 · 3
By mechanism
R01$4,898,872 · 3
Top collaborators
No co-investigators on record.
Most similar at Texas A&M Agrilife Research
Same institution · by research overlap
- Zach N Adelman$8,438,242
Others in their field
Top investigators on “Phosphorylation”
- Paul S. Aisen · Cognition Therapeutics, Inc.$88,828,963
- Alan F Horwitz · University Of Virginia Charlottesville$38,916,638
- Tony R. Hunter · Salk Institute For Biological Studies$34,955,666
- Adam L Boxer · Mayo Clinic Rochester$31,930,809
- Keith A. Johnson · Banner Health$30,350,302
- Paul Greengard · Rockefeller University$28,632,392
Research focus
PhosphorylationPlayKnockout MiceInsulin SignalingMolecularPathway InteractionsHyperglycemiaHomeostasisInsulinInsulin ResistanceLiverMetabolicNon-Insulin-Dependent Diabetes MellitusNuclearHepaticHepatocyteDiabetes MellitusCyclic Amp-Dependent Protein KinasesGene ExpressionGenesForkhead ProteinFoxo1a GeneGlucose ProductionProteins
Grant awards (14)
Hepatic TGFbeta1 in Control of Type 2 Diabetes and NASH via FoxO1 Signaling$499,701
R01 · FY2025 · DK · contact PI
Hepatic TGFbeta1 in Control of Type 2 Diabetes and NASH via FoxO1 Signaling$486,389
R01 · FY2024 · DK · contact PI
Hepatic TGFbeta1 in Control of Type 2 Diabetes and NASH via FoxO1 Signaling$513,385
R01 · FY2023 · DK · contact PI
Hepatic TGFbeta1 in Control of Type 2 Diabetes and NASH via FoxO1 Signaling$519,896
R01 · FY2022 · DK · contact PI
Targeting Insulin Resistance by Estrogen Receptor in Control of Type 2 Diabetes Mellitus$357,820
R01 · FY2022 · DK · contact PI
Targeting Insulin Resistance by Estrogen Receptor in Control of Type 2 Diabetes Mellitus$357,820
R01 · FY2021 · DK · contact PI
Targeting Insulin Resistance by Estrogen Receptor in Control of Type 2 Diabetes Mellitus$362,029
R01 · FY2020 · DK · contact PI
Targeting Insulin Resistance by Estrogen Receptor in Control of Type 2 Diabetes Mellitus$363,263
R01 · FY2019 · DK · contact PI
Transcriptional Regulation of Metabolic and Hepatic Homeostasis by FoxO Signaling$322,988
R01 · FY2016 · DK · contact PI
Transcriptional Regulation of Metabolic and Hepatic Homeostasis by FoxO Signaling$191,223
R01 · FY2015 · DK · contact PI
Transcriptional Regulation of Metabolic and Hepatic Homeostasis by FoxO Signaling$111,800
R01 · FY2015 · DK · contact PI
Transcriptional Regulation of Metabolic and Hepatic Homeostasis by FoxO Signaling$274,050
R01 · FY2014 · DK · contact PI
Transcriptional Regulation of Metabolic and Hepatic Homeostasis by FoxO Signaling$264,458
R01 · FY2013 · DK · contact PI
Transcriptional Regulation of Metabolic and Hepatic Homeostasis by FoxO Signaling$274,050
R01 · FY2012 · DK · contact PI